Immune-modulating effects of alpha-1 antitrypsin von Ehlers, Mario R.

Volltext

Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure von Arendse, Lauren B, Danser, A H Jan, Poglitsch, Marko, Touyz, Rhian M, Burnett, Jr, John C, Llorens-Cortes, Catherine, Ehlers, Mario R, Sturrock, Edward D

Volltext

Ace revisited: A new target for structure-based drug design von Acharya, K. Ravi, Sturrock, Edward D, Riordan, James F, Ehlers, Mario R. W

Volltext

Strategies for clinical trials in type 1 diabetes von Ehlers, Mario R

Volltext

Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial: Metabolic and Immunologic Features at... von Herold, Kevan C., Gitelman, Stephen E., Ehlers, Mario R., Gottlieb, Peter A., Greenbaum, Carla J., Hagopian, William, Boyle, Karen D., Keyes-Elstein, Lynette, Aggarwal, Sudeepta, Phippard, Deborah, Sayre, Peter H., McNamara, James, Bluestone, Jeffrey A.

Volltext

Restoring the balance: immunotherapeutic combinations for autoimmune disease von Smilek, Dawn E, Ehlers, Mario R, Nepom, Gerald T

Volltext

Immune interventions to preserve [beta] cell function in type 1 diabetes von Ehlers, Mario R

Volltext

Immune interventions to preserve β cell function in type 1 diabetes von Ehlers, Mario R

Volltext

Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function von LONG, S. Alice, RIECK, Mary, TURKA, Laurence A, EHLERS, Mario R, BIANCHINE, Peter J, BOYLE, Karen D, ADAH, Steven A, BLUESTONE, Jeffrey A, BUCKNER, Jane H, GREENBAUM, Carla J, SANDA, Srinath, BOLLYKY, Jennifer B, SAMUELS, Peter L, GOLAND, Robin, AHMANN, Andrew, RABINOVITCH, Alex, AGGARWAL, Sudeepta, PHIPPARD, Deborah

Volltext

Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients von Rigby, Mark R, Harris, Kristina M, Pinckney, Ashley, DiMeglio, Linda A, Rendell, Marc S, Felner, Eric I, Dostou, Jean M, Gitelman, Stephen E, Griffin, Kurt J, Tsalikian, Eva, Gottlieb, Peter A, Greenbaum, Carla J, Sherry, Nicole A, Moore, Wayne V, Monzavi, Roshanak, Willi, Steven M, Raskin, Philip, Keyes-Elstein, Lynette, Long, S Alice, Kanaparthi, Sai, Lim, Noha, Phippard, Deborah, Soppe, Carol L, Fitzgibbon, Margret L, McNamara, James, Nepom, Gerald T, Ehlers, Mario R

Volltext

Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trial von Gitelman, Stephen E., Gottlieb, Peter A., Felner, Eric I., Willi, Steven M., Fisher, Lynda K., Moran, Antoinette, Gottschalk, Michael, Moore, Wayne V., Pinckney, Ashley, Keyes-Elstein, Lynette, Harris, Kristina M., Kanaparthi, Sai, Phippard, Deborah, Ding, Linna, Bluestone, Jeffrey A., Ehlers, Mario R.

Volltext

Immune Interventions to Preserve β Cell Function in Type 1 Diabetes von Ehlers, Mario R

Volltext

Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial von Gitelman, Stephen E, Prof, Gottlieb, Peter A, Prof, Rigby, Mark R, Prof, Felner, Eric I, Prof, Willi, Steven M, MD, Fisher, Lynda K, MD, Moran, Antoinette, Prof, Gottschalk, Michael, Prof, Moore, Wayne V, MD, Pinckney, Ashley, MS, Keyes-Elstein, Lynette, PhD, Aggarwal, Sudeepta, PhD, Phippard, Deborah, PhD, Sayre, Peter H, Prof, Ding, Linna, PhD, Bluestone, Jeffrey A, Prof, Ehlers, Mario R, MBChB

Volltext

Targeting Memory T Cells in Type 1 Diabetes von Ehlers, Mario R., Rigby, Mark R.

Volltext

Changes in T‐cell subsets identify responders to FcR‐nonbinding anti‐CD3 mAb (teplizumab) in patients with type 1 diabetes von Tooley, James E., Vudattu, Nalini, Choi, Jinmyung, Cotsapas, Chris, Devine, Lesley, Raddassi, Khadir, Ehlers, Mario R., McNamara, James G., Harris, Kristina M., Kanaparthi, Sai, Phippard, Deborah, Herold, Kevan C.

Volltext

Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data from the Immune... von Pinckney, Ashley, MS, Rigby, Mark R., MD, PhD, Keyes-Elstein, Lynette, DrPH, Soppe, Carol L., MS, Nepom, Gerald T., MD, PhD, Ehlers, Mario R., MBChB, PhD

Volltext

Glycan microarray reveal induced IgGs repertoire shift against a dietary carbohydrate in response to rabbit anti-human thymocyte therapy von Amon, Ron, Ben-Arye, Shani Leviatan, Engler, Limor, Yu, Hai, Lim, Noha, Berre, Ludmilla Le, Harris, Kristina M, Ehlers, Mario R, Gitelman, Stephen E, Chen, Xi, Soulillou, Jean-Paul, Padler-Karavani, Vered

Volltext

Anti-Gal and Anti-Neu5Gc Responses in Nonimmunosuppressed Patients After Treatment With Rabbit Antithymocyte Polyclonal IgGs von Salama, Apolline, Evanno, Gwénaëlle, Lim, Noha, Rousse, Juliette, Le Berre, Ludmilla, Nicot, Arnaud, Bach, Jean-Marie, Brouard, Sophie, Harris, Kristina M, Ehlers, Mario R, Gitelman, Stephen E, Soulillou, Jean-Paul

Volltext

A Preclinical Consortium Approach for Assessing the Efficacy of Combined Anti-CD3 Plus IL-1 Blockade in Reversing New-Onset Autoimmune Diabetes in NOD Mice von Gill, Ronald G, Pagni, Philippe P, Kupfer, Tinalyn, Wasserfall, Clive H, Deng, Songyan, Posgai, Amanda, Manenkova, Yulia, Bel Hani, Amira, Straub, Laura, Bernstein, Philip, Atkinson, Mark A, Herold, Kevan C, von Herrath, Matthias, Staeva, Teodora, Ehlers, Mario R, Nepom, Gerald T

Volltext

Targeted immune interventions for type 1 diabetes: not as easy as it looks von Rigby, Mark R., Ehlers, Mario R.

Volltext